Filtered By:
Condition: Chronic Obstructive Pulmonary
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1666 results found since Jan 2013.
Eosinophilic bronchiectasis and therapeutic oportunities
Bronchiectasis is the third most frequent chronic inflammatory disease of the airways after chronic obstructive pulmonary disease (COPD) and asthma. Its diagnosis is established by clinical and radiological criteria based on the abnormal dilation of the bronchial lumen together with a clinical picture compatible with the inflammatory-infectious process causing the destruction of the bronchial wall and producing its dilation. This picture generally consists of a productive cough (often with a purulent component) and a variable number of exacerbations throughout the natural history of the disease 1.
Source: Annals of Allergy, Asthma and Immunology - September 21, 2023 Category: Allergy & Immunology Authors: Grace Oscullo, Jose Daniel Gomez-Olivas, Miguel Ángel Martínez-García Tags: Editorial Source Type: research
ERS Roundup: Cell Transplant Boosts Lung Function in COPD Patients
(MedPage Today) -- MILAN -- Research presented at this year's annual European Respiratory Society congress included early successes in transplanting a patient's own lung cells to ease chronic obstructive pulmonary disease (COPD), idrevloride...
Source: MedPage Today Allergy - September 16, 2023 Category: Allergy & Immunology Source Type: news
Acetazolamide May Help COPD Patients Reach New Heights
(MedPage Today) -- Acetazolamide may prevent some patients with chronic obstructive pulmonary disease (COPD) from suffering altitude-related adverse health effects (ARAHE) when traveling, a randomized controlled trial showed.
In patients with...
Source: MedPage Today Allergy - September 14, 2023 Category: Allergy & Immunology Source Type: news
E-cigarette vapour renders neutrophils dysfunctional due to filamentous actin accumulation
Electronic (e-)cigarette use continues to rise despite concerns of long-term effects, especially the risk of developing lung diseases such as chronic obstructive pulmonary disease (COPD). Neutrophils are central to the pathogenesis of COPD, with changes in phenotype and function implicated in tissue damage.
Source: Journal of Allergy and Clinical Immunology - September 4, 2023 Category: Allergy & Immunology Authors: Alice E. Jasper, Aduragbemi A. Faniyi, Lauren C. Davis, Frances S. Grudzinska, Robyn Halston, Jon Hazeldine, Dhruv Parekh, Elizabeth Sapey, David R. Thickett, Aaron Scott Source Type: research
Comprehensive care of adults with respiratory diseases must include vaccines
Vaccines are among the most effective tools we have to improve and save lives, but only if they are administered to eligible patients. In this issue, Naeger et al1 highlight the major opportunities that the health care community has to achieve high adult vaccination rates. These vaccines include those for prevention of coronavirus disease 2019 (COVID-19), pneumococcal, and influenza, diseases that respiratory health professionals are most aware of, plus pertussis (in Tdap), herpes zoster (HZ, shingles), and as of May 3, 2023, respiratory syncytial viral, for which adults with asthma and chronic obstructive pulmonary diseas...
Source: Annals of Allergy, Asthma and Immunology - September 1, 2023 Category: Allergy & Immunology Authors: Barbara P. Yawn, Dennis Williams, Gregory Poland Tags: Editorial Source Type: research
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
CONCLUSION: In a global study, comorbidity or multimorbidity is reported in most adults with severe asthma and is associated with poorer asthma-related outcomes.PMID:37640263 | DOI:10.1016/j.anai.2023.08.021
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ghislaine Scelo Carlos A Torres-Duque Jorge Maspero Trung N Tran Ruth Murray Neil Martin Andrew N Menzies-Gow Mark Hew Matthew J Peters Peter G Gibson George C Christoff Todor A Popov Andr éanne Côté Celine Bergeron Delbert Dorscheid J Mark FitzGerald Source Type: research
Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US
CONCLUSION: Onset of the COVID-19 pandemic coincided with reductions in acute care utilization for asthma and COPD. Understanding the mechanism of this reduction might inform future efforts to prevent exacerbations.PMID:37619778 | DOI:10.1016/j.anai.2023.08.016
Source: Annals of Allergy, Asthma and Immunology - August 24, 2023 Category: Allergy & Immunology Authors: Adam Gaffney David U Himmelstein Steffie Woolhandler Source Type: research
The lung-gut crosstalk in respiratory and inflammatory bowel disease
Both lung and gut belong to the common mucosal immune system (CMIS), with huge surface areas exposed to the external environment. They are the main defense organs against the invasion of pathogens and play a key role in innate and adaptive immunity. Recently, more and more evidence showed that stimulation of one organ can affect the other, as exemplified by intestinal complications during respiratory disease and vice versa, which is called lung-gut crosstalk. Intestinal microbiota plays an important role in respiratory and intestinal diseases. It is known that intestinal microbial imbalance is related to inflammatory bowel...
Source: Frontiers in cellular and infection microbiology - August 23, 2023 Category: Microbiology Source Type: research
COPD Inhalers' Link to Fracture Risk Supported in Pooled Trials
(MedPage Today) -- Chronic obstructive pulmonary disease (COPD) treatments involving inhaled corticosteroids (ICSs) were associated with a greater risk for fractures, a meta-analysis of several dozen randomized trials found.
Use of inhaled ICSs...
Source: MedPage Today Allergy - August 22, 2023 Category: Allergy & Immunology Source Type: news
Population-level trends in asthma and chronic obstructive pulmonary disease emergency department visits and hospitalizations before and during the coronavirus disease 2019 pandemic in the United States
Previous studies have identified reductions in exacerbations of chronic lung disease in many locales after onset of the coronavirus disease 2019 (COVID-19) pandemic.
Source: Annals of Allergy, Asthma and Immunology - August 22, 2023 Category: Allergy & Immunology Authors: Adam Gaffney, David U. Himmelstein, Steffie Woolhandler Source Type: research
Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US
Previous studies have identified reductions in exacerbations of chronic lung disease in many locales after onset of the COVID-19 pandemic.
Source: Annals of Allergy, Asthma and Immunology - August 22, 2023 Category: Allergy & Immunology Authors: Adam Gaffney, David U. Himmelstein, Steffie Woolhandler Tags: Original Article Source Type: research
Simplifying pharmacotherapy for patients with COPD: a viewpoint
Source: European Respiratory Journal - August 17, 2023 Category: Respiratory Medicine Authors: Celli, B., Vestbo, J. Tags: Asthma and allergy Editorials Source Type: research
Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease
Asthma and chronic obstructive pulmonary disease (COPD) have distinct and overlapping genetic and clinical features.
Source: Journal of Allergy and Clinical Immunology - August 16, 2023 Category: Allergy & Immunology Authors: Matthew Moll, Joanne E. Sordillo, Auyon J. Ghosh, Lystra P. Hayden, Gregory McDermott, Michael J. McGeachie, Amber Dahlin, Anshul Tiwari, Monica G. Manmadkar, Eric D. Abston, Chandan Pavuluri, Aabida Saferali, Sofina Begum, John P. Ziniti, Amund Gulsvik, Source Type: research
